Medicinal and recreational uses of Cannabis sativa, commonly known as cannabis or hemp,
has increased following its legalization in certain regions of the world. Cannabis and hemp …

Liver disease resulting from heart failure (HF) has generally been referred as “cardiac
hepatopathy”. One of its main forms is congestive hepatopathy (CH), which results from …

Although the burden of end-stage heart failure continues to increase, the number of
available organs for heart transplantation (HT) remains inadequate. The HT community has …

Endomyocardial biopsy (EMB) is an invaluable and underused diagnostic tool for
myocardial disease. The primary indications are surveillance of cardiac allograft rejection …

Cardiac allograft vasculopathy (CAV) is a unique form of accelerated atherosclerosis that
represents the main late cause of morbidity and mortality, affecting almost half patients at ten …

Adults with congenital heart disease (ACHD) experience worse waitlist outcomes and higher
early posttransplant mortality compared to non-ACHD patients. On October 18, 2018; the …

Cardiovascular complications from drugs of abuse are becoming more apparent because of
increased usage worldwide. Substance abuse can cause acute and chronic cardiovascular …

Cardiac allograft vasculopathy (CAV) is an obliterative and diffuse form of vasculopathy
affecting almost 50% of patients after 10 years from heart transplant and represents the most …

In this review, we provide a comprehensive overview of the impact of the COVID-19
pandemic on adult heart transplantation. We highlight the decline in the number of adult …

Cardiac allograft vasculopathy (CAV) continues to be a significant risk factor for the
recipient's long-term survival following heart transplantation. Our knowledge of its etiology is …